Business Description
GlycoMimetics Inc
NAICS : 325412
SIC : 2834
ISIN : US38000Q1022
Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 49.57 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -19.74 | |||||
Beneish M-Score | -0.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 19.7 | |||||
3-Year FCF Growth Rate | 13.8 | |||||
3-Year Book Growth Rate | -38.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.15 | |||||
9-Day RSI | 44.76 | |||||
14-Day RSI | 37.36 | |||||
6-1 Month Momentum % | -90.97 | |||||
12-1 Month Momentum % | -84.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.28 | |||||
Quick Ratio | 6.28 | |||||
Cash Ratio | 5.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.5 | |||||
Shareholder Yield % | 0.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -394490 | |||||
Net Margin % | -372780 | |||||
FCF Margin % | -338090 | |||||
ROE % | -80.74 | |||||
ROA % | -70.75 | |||||
ROIC % | -952.92 | |||||
ROC (Joel Greenblatt) % | -4347.48 | |||||
ROCE % | -85.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.6 | |||||
Price-to-Tangible-Book | 0.6 | |||||
EV-to-EBIT | 0.33 | |||||
EV-to-EBITDA | 0.33 | |||||
EV-to-Revenue | -1294.2 | |||||
EV-to-FCF | 0.39 | |||||
Price-to-Net-Current-Asset-Value | 0.63 | |||||
Price-to-Net-Cash | 0.68 | |||||
Earnings Yield (Greenblatt) % | 303.03 | |||||
FCF Yield % | -193.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLYC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlycoMimetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.01 | ||
EPS (TTM) ($) | -0.58 | ||
Beta | 2.18 | ||
Volatility % | 117.45 | ||
14-Day RSI | 37.36 | ||
14-Day ATR ($) | 0.047887 | ||
20-Day SMA ($) | 0.27134 | ||
12-1 Month Momentum % | -84.18 | ||
52-Week Range ($) | 0.235 - 3.5299 | ||
Shares Outstanding (Mil) | 64.46 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GlycoMimetics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GlycoMimetics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
GlycoMimetics Inc Frequently Asked Questions
What is GlycoMimetics Inc(GLYC)'s stock price today?
The current price of GLYC is $0.27. The 52 week high of GLYC is $3.53 and 52 week low is $0.24.
When is next earnings date of GlycoMimetics Inc(GLYC)?
The next earnings date of GlycoMimetics Inc(GLYC) is 2024-08-02 Est..
Does GlycoMimetics Inc(GLYC) pay dividends? If so, how much?
GlycoMimetics Inc(GLYC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |